{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:19:21Z","timestamp":1791389961130,"version":"4.3.3"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T00:00:00Z","timestamp":1640304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> The quantitative myasthenia gravis score is a commonly used scale for evaluating muscle weakness associated with myasthenia gravis (MG). It has been reported that some items used in the scale have low discriminative properties. However, there has been no research investigating the applicability of the quantitative MG score (QMGS) in Chinese patients with MG. In addition, the scoring method and ranges of grip strength items in QMGS need to be further evaluated.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This study included 106 Chinese patients with MG, enrolled between September 2020 and February 2021, who were evaluated using the QMGS. Each item in the QMGS was analyzed for distribution. Three methods of evaluating grip strength, grip strength decrement, maximum grip strength, and relative grip strength, were compared. The correlation between the QMG total score minus grip strength score, and three evaluating methods, was analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The grip strength, swallowing, speech, diplopia, ptosis, and facial muscles items showed a clustered distribution. Most patients (94%) presented their maximum grip strength in the first four grip strength measurements. The QMG total score minus the grip strength score had a weak correlation with grip strength decrement (R grip <jats:italic>r<\/jats:italic> = 0.276; L grip <jats:italic>r<\/jats:italic> = 0.353, both <jats:italic>p<\/jats:italic> &amp;lt; 0.05) and moderate correlations with maximum grip strength (R grip <jats:italic>r<\/jats:italic> = \u22120.508; L grip <jats:italic>r<\/jats:italic> = \u22120.507; both <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and relative grip strength (R grip <jats:italic>r<\/jats:italic> = \u22120.494; L grip <jats:italic>r<\/jats:italic> = \u22120.497, both <jats:italic>p<\/jats:italic> &amp;lt; 0.001).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This study suggested that partial items in the QMGS have low discriminative properties for Chinese populations and the maximum grip strength value is the better method to evaluate grip strength compared to the other two scoring methods. Based on the quartiles of maximum grip strength, we propose new scoring ranges for the grip strength items.<\/jats:p>","DOI":"10.3389\/fneur.2021.782980","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T05:11:48Z","timestamp":1640322708000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinghao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senhui","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nmd.2013.02.008","article-title":"Performance of individual items of the quantitative myasthenia gravis score","volume":"23","author":"Barnett","year":"2013","journal-title":"Neuromuscul Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/ageing\/afv192","article-title":"Global variation in grip strength: a systematic review and meta-analysis of normative data","volume":"45","author":"Dodds","year":"2016","journal-title":"Age Ageing."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00198-017-4041-0","article-title":"Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study","volume":"28","author":"Guan","year":"2017","journal-title":"Osteoporosis Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.amepre.2015.10.022","article-title":"Ogden C. Associations of relative handgrip strength and cardiovascular disease biomarkers in US adults","volume":"50","author":"Lawman","year":"2016","journal-title":"Am J Prevent Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1183\/09031936.00091612","article-title":"Defining race\/ethnicity and explaining difference in research studies on lung function","volume":"41","author":"Braun","year":"2013","journal-title":"Eur Respir J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e113637","DOI":"10.1371\/journal.pone.0113637","article-title":"Grip strength across the life course: normative data from twelve British studies","volume":"9","author":"Dodds","year":"2014","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mus.25529","article-title":"and MG-ADL correlations: study of eculizumab treatment of myasthenia gravis","volume":"56","author":"Howard","year":"2017","journal-title":"Muscle Nerve."},{"key":"B15","doi-asserted-by":"publisher","first-page":"17562864211001995","DOI":"10.1177\/17562864211001995","article-title":"Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance","volume":"14","author":"Murai","year":"2021","journal-title":"Ther Adv Neurol Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1212\/WNL.0000000000011108","article-title":"Efficacy and safety of Rozanolixizumab in moderate to severe generalized myasthenia gravis: a phase 2 randomized control trial","volume":"96","author":"Bril","year":"2021","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S1474-4422(18)30037-1","article-title":"Distinct representation of muscle weakness in QMG and MG-ADL","volume":"17","author":"de Meel","year":"2018","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(18)30036-X","article-title":"Distinct representation of muscle weakness in QMG and MG-ADL\u2014authors' reply","volume":"17","author":"Howard","year":"2018","journal-title":"Lancet Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.782980\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T05:11:49Z","timestamp":1640322709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.782980\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,24]]},"references-count":18,"alternative-id":["10.3389\/fneur.2021.782980"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.782980","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,24]]},"article-number":"782980"}}